KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
+21.24%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$179M
AUM Growth
–
Cap. Flow
+$179M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
69.33%
Holding
26
New
26
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
United Therapeutics
UTHR
|
$16.2M |
| 2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$14.9M |
| 3 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
$13.7M |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$13.4M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$12.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 65.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $16.2M | 9% | +124,801 | New | +$16.2M |
|
|
AMAG
2
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $14.9M | 8.29% | +349,042 | New | +$14.9M |
|
|
SCMP
3
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $13.7M | 7.62% | +958,048 | New | +$13.7M |
|
|
IPXL
4
DELISTED
Impax Laboratories, Inc.
IPXL
| $13.4M | 7.47% | +423,161 | New | +$13.4M |
|
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $12.6M | 7.02% | +219,200 | New | +$12.6M |
|
6
Avanos Medical
AVNS
$554M
| $12.2M | 6.78% | +267,450 | New | +$12.2M |
|
7
CONMED
CNMD
$1.68B
| $11.6M | 6.47% | +258,117 | New | +$11.6M |
|
8
Merck
MRK
$210B
| $11.6M | 6.46% | +204,100 | New | +$11.6M |
|
9
Orthofix Medical
OFIX
$592M
| $9.39M | 5.23% | +312,470 | New | +$9.39M |
|
|
HRC
10
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.95M | 4.98% | +196,100 | New | +$8.95M |
|
|
SRGA
11
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $8.59M | 4.79% | +1,651,458 | New | +$8.59M |
|
12
Assertio
ASRT
$80.4M
| $6.16M | 3.43% | +382,542 | New | +$6.16M |
|
|
AGN
13
DELISTED
Allergan plc
AGN
| $5.93M | 3.3% | +23,016 | New | +$5.93M |
|
|
IVC
14
DELISTED
Invacare Corporation
IVC
| $5.61M | 3.13% | +334,762 | New | +$5.61M |
|
|
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.99M | 2.78% | +50,395 | New | +$4.99M |
|
16
AbbVie
ABBV
$372B
| $4.94M | 2.75% | +75,500 | New | +$4.94M |
|
17
Amgen
AMGN
$155B
| $4.62M | 2.57% | +29,000 | New | +$4.62M |
|
|
MDCO
18
DELISTED
Medicines Co
MDCO
| $3.56M | 1.98% | +128,600 | New | +$3.56M |
|
|
VXRT
19
DELISTED
Vaxart
VXRT
| $2.57M | 1.43% | +1,147,130 | New | +$2.57M |
|
20
Innoviva
INVA
$1.29B
| $2.43M | 1.36% | +171,859 | New | +$2.43M |
|
|
STRR
21
DELISTED
Star Equity Holdings
STRR
| $1.83M | 1.02% | +419,604 | New | +$1.83M |
|
|
JNP
22
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.77M | 0.99% | +316,149 | New | +$1.77M |
|
|
FURX
23
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $1.42M | 0.79% | +145,544 | New | +$1.42M |
|
24
Pfizer
PFE
$141B
| $419K | 0.23% | +13,447 | New | +$419K |
|
25
Eli Lilly
LLY
$657B
| $148K | 0.08% | +2,143 | New | +$148K |
|